Yale University researcher Akiko Iwasaki, Ph.D., says immune profiling shows how Long COVID patients have distinct features not found in control groups. These patients, who also exhibit elevated levels of exhausted T-cells, cause her to express surprise at skeptics.
Iwasaki joins Fiona Lowenstein, editor of “The Long COVID Survival Guide,” to discuss patients who say they’re suffering from Long COVID for as much as two years after their acute phase of the disease.
Iwasaki also explains why her lab’s effort to move forward with a COVID nasal spray faces financial hurdles.
Listen in to this important conversation with hosts Mark Masselli and Margaret Flinter.
Podcast: Play in new window | Download
Subscribe: Apple Podcasts | Spotify | Android | Podchaser | TuneIn | RSS | More
Originally broadcast January 30, 2025. Noted healthcare leader Dr. Sachin Jain has been publicly releasing…
Originally broadcast January 23, 2025 President Trump’s first days in office have resulted in a…
Originally broadcast August 22, 2023 As the year begins, some patients remain concerned about how…
Originally broadcast June 8, 2023 The World Health Organization has issued a statement expressing concern…
Originally broadcast January 2, 2025. Conversations on Health Care hopes the new year is off…
Originally broadcast December 26, 2024 Dr. Amit Sood is called the “Happiness Doctor” for a…